JM Smucker Company (NYSE: SJM) reported fourth-quarter financial results before the opening bell on Thursday.
The company reported an 8% decrease in Q4 net sales to $1.92 billion, which was higher than the Wall Street consensus.
The net earnings were $147 million or $1.35 per share compared to $226.3 or $1.98 per share of the same quarter in the previous year.
The adjusted earnings was reported at $1.89, a decrease of 26%.
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated